On June 3, 1965, Ed White made history as the first American to walk in space during the Gemini 4 mission. Discover the thrilling details of this groundbreaking achievement and its significance in space exploration!
In a revealing interview, Dr. Marty Makary, FDA commissioner, raises concerns over past Covid-19 vaccine recommendations, emphasizing the importance of discussions between patients and their doctors.
In a recent interview, FDA Commissioner Marty Makary sparked controversy by urging Americans to consult their doctors regarding Covid-19 vaccines, citing mixed data on their safety for children and pregnant individuals. As the government alters vaccine recommendations, public health experts express concern over potential risks.
In a groundbreaking move, the FDA has approved Moderna's lower-dose Covid-19 vaccine for older adults and at-risk individuals. Get ready for a new option this fall as Moderna targets the LP.8.1 variant!
In a historic upset, Wright State eliminated top-seeded Vanderbilt from the NCAA tournament with a thrilling 5-4 victory. Key performances from Boston Smith and Griffen Paige led the Raiders to a stunning win.
A new COVID-19 variant, NB.1.8.1, is spreading quickly in California, leading health experts to warn of a potential summer surge. Learn about the symptoms, vaccine effectiveness, and what residents should know.
Robert F. Kennedy Jr. canceled a critical $766 million contract with Moderna for a bird flu vaccine, raising concerns about public health and vaccine safety amidst a potential outbreak.
In a stunning turn of events, Lance Stroll will not be competing in the Grand Prix due to a hand injury, leaving 19 cars to vie for victory. What does this mean for the race dynamics?
The Trump administration's sudden cancellation of a $258 million HIV vaccine research program has ignited outrage among scientists and public health advocates, jeopardizing years of progress in HIV prevention and treatment as infection rates surge.
The U.S. has approved Moderna's new COVID-19 vaccine, mNexspike, specifically for high-risk groups. This innovative option offers a lower dose while maintaining effectiveness, marking a pivotal step in the fight against coronavirus.
